Guided Therapeutics, Inc. (GTHP)
OTCMKTS: GTHP · Delayed Price · USD
0.100
+0.013 (14.81%)
May 3, 2024, 12:21 PM EDT - Market closed

Guided Therapeutics Revenue

In the year 2023, Guided Therapeutics had annual revenue of $98.00K with 653.85% growth. Revenue in the quarter ending December 31, 2023 was $32.00K with 220.00% year-over-year growth.

Revenue (ttm)
$98.00K
Revenue Growth
+326.09%
P/S Ratio
56.75
Revenue / Employee
$24,500
Employees
4
Market Cap
5.56M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202398.00K85.00K653.85%
Dec 31, 202213.00K-68.00K-83.95%
Dec 31, 202181.00K-21.00K-20.59%
Dec 31, 2020102.00K66.00K183.33%
Dec 31, 201936.00K-21.00K-36.84%
Dec 31, 201857.00K-187.00K-76.64%
Dec 31, 2017244.00K-361.00K-59.67%
Dec 31, 2016605.00K-1.00K-0.17%
Dec 31, 2015606.00K-217.00K-26.37%
Dec 31, 2014823.00K-356.00K-30.20%
Dec 31, 20131.18M-2.23M-65.43%
Dec 31, 20123.41M-187.00K-5.20%
Dec 31, 20113.60M233.00K6.93%
Dec 31, 20103.36M1.81M117.03%
Dec 31, 20091.55M233.00K17.69%
Dec 31, 20081.32M280.00K27.00%
Dec 31, 20071.04M60.00K6.14%
Dec 31, 2006977.00K-6.00K-0.61%
Dec 31, 2005983.00K-90.00K-8.39%
Dec 31, 20041.07M-513.00K-32.35%
Dec 31, 20031.59M-2.21M-58.24%
Dec 31, 20023.80M1.34M54.52%
Dec 31, 20012.46M-2.51M-50.52%
Dec 31, 20004.97M1.67M50.55%
Dec 31, 19993.30M1.90M135.71%
Dec 31, 19981.40M500.00K55.56%
Dec 31, 1997900.00K400.00K80.00%
Dec 31, 1996500.00K-680.00K-57.63%
Dec 31, 19951.18M1.06M883.33%
Dec 31, 1994120.00K--
Dec 31, 19930--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 81.80B
Merck & Co. 60.12B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings